Project Contour is the asset sale of a direct-to-consumer brand built on a patented, FDA-registered at-home cosmetic device, an alternative to injectables sold through its own storefront sinceredactedThe business is debt-free and forecasts $1.93M of SDE in 2026 at a 47% margin, earns an 89% contribution margin on each order, and has served more than 200,000 customers. Run part-time by the owner and one operations lead, it has untapped channels (Amazon, retail, international) and two product launches planned forredactedThe brand, patent, molds, customer file and supply chain all transfer, and the seller is available to support the transition.